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Not Making the Grade*Saibal Kar, MD, Rahul Sharma, MDM itral regurgitation (MR) is a commonvalvular disorder affecting more than 2million people in the United States (1).
The etiology of MR can be divided into primary MR,
caused by pathology of the valve apparatus, and sec-
ondary MR, a functional consequence of ventricular
dysfunction. The clinical course of MR is generally
insidious, and if left untreated, leads to heart failure
and ultimately death. The most challenging aspect
in the management of MR is accurate quantiﬁcation
of severity and consequent decision regarding timing
of intervention.
To date, echocardiography has been the gold
standard tool of investigation (2). Despite technolog-
ical advancements, there are limitations regarding its
utility for the quantiﬁcation of MR. First, obtaining
accurate data is heavily operator dependent and
limited by patient habitus and acoustic windows.
Further difﬁculties are encountered with prosthetic
valves or rings, which cause acoustic shadowing.
Transcatheter mitral valve repair using the Mitra-
Clip (Abbott Vascular, Santa Rosa, California) to
create a double oriﬁce mitral valve has emerged as a
treatment for selected patients with severe MR.
Unfortunately, most qualitative and quantitative
echocardiographic methods have not been validated
in a double-oriﬁce valve model. The creation of high-
velocity jets on either side of the clip may give the
appearance of signiﬁcant residual MR, even though
the actual regurgitant volume is low (3). In the
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reduction of MR compared with the surgical arm.
However, at 4 years, there was equivalent clinical
beneﬁt with evidence of favorable remodeling in both
groups. It is quite possible that creation of a double
oriﬁce resulted in an overestimation of MR grade in
the MitraClip arm (4). A further limitation of echo-
cardiography is the signiﬁcant degree of interob-
server variability, which poses potential difﬁculties
when monitoring response to treatment. Importantly,
no single echocardiographic parameter is sufﬁcient
to accurately assess the severity of MR. Indeed,
assessment is dependent on integrating a number of
parameters based on anatomic and Doppler criteria.
Finally, MR severity is traditionally described in a
categorical fashion, encompassing mild, moderate, or
severe—or graded from 1 to 4. Perhaps, however,
MR severity should be considered as a continuous
variable, akin to other standard echocardiographic
parameters such as ventricular dimensions and ejec-
tion fraction. This should be based on an accurate
assessment of regurgitant volume/fraction. Unfortu-
nately, current echocardiographic methods limit
accurate and reliable assessment of volumes.
The utility of magnetic resonance imaging (MRI)
for the assessment of valvular disease is well estab-
lished (5). Compared with echocardiography, MRI
offers a number of advantages. First and foremost,
MRI has superior spatial and temporal resolution,
with less operator dependency than echocardiogra-
phy, relying on complex analytical algorithms to
enable measurements in a 3-dimensional fashion
without making geometric assumptions (5). MRI is
not dependent on body habitus and can be performed
in various planes without limitation of acoustic win-
dows. MRI quantiﬁcation of MR is based on calcula-
tion of regurgitant volume, which is derived as the
difference between aortic forward stroke volume
(based on phase contrast imaging) and total left
ventricular (LV) stroke volume (based on planimetry
FIGURE 1 Schematic Diagram Showing the Principle of Estimation of Mitral Regurgitant Volume Using Cardiac MRI
Example of the method used to calculate mitral regurgitant volume (see text for details). Ao ¼ aorta; EDV ¼ end-diastolic volume;
ESV ¼ end-systolic volume; LA ¼ left atrium; LV ¼ left ventricular; MR ¼ mitral regurgitation; MRI ¼ magnetic resonance imaging;
SV ¼ stroke volume.
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(Figure 1) (6). This approach has been shown to have
low variability and excellent reproducibility in
several studies, making it an optimal technique for
serial assessment (5,7). However, MRI does have
some limitations including limited availability,
increased cost, lengthy scan sequences (difﬁcult for
patients with claustrophobia), and incompatibly with
many ferromagnetic devices. As such, MRI is not as
widely used in the real-world setting.SEE PAGE 1078In this issue of the Journal, Uretsky et al. (8)
uniquely compared the degree of postoperative
negative remodeling with preoperative regurgitant
volume, thereby providing a reference standard with
which to support the greater accuracy of MRI
compared with echocardiography. Furthermore, the
methodology is robust, with studies interpreted in a
central core laboratory by experienced, blinded
readers and separate analyses performed in both
groups to assess interobserver variability.
The majority of patients in this study had degen-
erative (primary) MR. Importantly, there were no
signiﬁcant differences in loading conditions as
assessed by blood pressure and heart rate between
MRI and echocardiography at the time of assessment.
MRI demonstrated less interobserver variability withexcellent reproducibility compared with echocardi-
ography (90% vs. 61%). The concordance between
both techniques was poor, improving only modestly
when patients were reclassiﬁed as either severe or
nonsevere. A staggering ﬁnding was that only 22%
of patients deemed to have severe MR by echocardi-
ography were graded accordingly by MRI. This dis-
crepancy also was reﬂected to a similar degree in the
studies assessed for interobserver variability. The
degree of discordance was impressive, with 34% of
patients classiﬁed as having severe MR by echocar-
diography, having only mild MR as assessed by MRI.
On the other hand, in cases of mild MR as assessed
by echocardiography, there was agreement by MRI.
Somewhat disconcerting is that of the patients who
underwent surgery based on Class I/IIa recommen-
dation, only 30% actually had severe MR according to
MRI assessment. As expected after surgery, LV vol-
umes and LV ejection fraction decreased. There was a
signiﬁcant difference in the decrease in LV end-
diastolic volume and regurgitant volume across all
categories of severity by MRI, a ﬁnding not mirrored
by echocardiography.
Despite using robust methodology in imaging
assessment and highlighting an obvious disparity
between echocardiography and MRI, this study did
have 2 key limitations. First, despite being a multi-
center study, the ﬁnal number of patients who
J A C C V O L . 6 5 , N O . 1 1 , 2 0 1 5 Kar and Sharma
M A R C H 2 4 , 2 0 1 5 : 1 0 8 9 – 9 1 Current Assessment of Mitral Regurgitation: Not Making the Grade
1091underwent mitral valve surgery and for whom com-
plete imaging assessment was available was small,
limiting generalizability. Second, the clinical rele-
vance of the discordance between MRI and echocar-
diography in the assessment of MR severity and its
subsequent impact on treatment was not assessed,
and therefore no conclusions can be drawn regarding
clinical outcomes.
Mitral regurgitation is a prevalent pathology with
signiﬁcant implications for morbidity and mortality
when not treated appropriately. Recent guideline
revisions identify asymptomatic patients with
severe MR as those who may warrant surgical treat-
ment. Echocardiography is a cost-effective, readily
available, and well-established investigative tool.
However, it is limited by patient anatomic fac-
tors, interobserver variability, and assessment of
numerous factors to improve diagnostic accuracy. In
contrast, MRI, although more expensive and less
readily available, provides superior imaging with less
interobserver variability, better reproducibility, and
greater accuracy in the assessment of MR severity.
Moreover, MRI appears to correlate better withimprovements after surgery compared with echocar-
diography. However, the clinical relevance of these
differences needs to be elucidated. Thus, these study
results need to be reﬂected in larger studies to
determine generalizability.
On balance, it would seem reasonable that echo-
cardiography remain the ﬁrst-line investigation for
patients with suspected MR. Those with mild MR
could be monitored clinically. In those with moderate
or severe MR, particularly asymptomatic patients, MRI
may be indicated to conﬁrm the degree of severity
before subjecting the patient to invasive therapy.
After intervention, MRI may be more appropriate for
serial monitoring. Finally, with improvements in all
imaging modalities, we hope that in the future the
severity of MR will not be characterized categorically
as mild/moderate/severe but rather as a continuous
variable incorporating regurgitant volume/fraction.
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